Format

Send to

Choose Destination
See comment in PubMed Commons below
J Allergy Clin Immunol. 2009 Jul;124(1):81-9. doi: 10.1016/j.jaci.2009.04.026. Epub 2009 Jun 11.

IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes.

Author information

1
Department of Immunodermatology and Allergy Research, Hannover Medical School, Hannover, Germany. M.Wittmann@leeds.ac.uk

Abstract

BACKGROUND:

IL-27 is produced by antigen-presenting cells early during immune responses. IL-27 has been described to support T-cell polarization along the T(H)1 lineage but also to exert important anti-inflammatory responses in later phases of inflammation in murine models.

OBJECTIVE:

It was the aim of this study to analyze the potential role of IL-27 in epidermal inflammatory skin responses in human subjects.

METHODS:

Surface receptor expression and apoptosis of human primary keratinocytes were analyzed by means of flow cytometry. Supernatants of stimulated keratinocytes were either analyzed by means of ELISA or submitted to chemotaxis assays. RT-PCR from lesional skin and phospho-specific Western blotting were performed.

RESULTS:

Both subunits of IL-27 were expressed in chronic lesional allergic eczematous skin, whereas the IL-27 subunit EBV-induced gene 3 was not detectable in the acute phase of eczema. Human primary keratinocytes responded to IL-27. Stimulation of keratinocytes with IL-27 resulted in activation of the signal transducer and activator of transcription 1 and 3 pathways. Major effects found for IL-27 include CXCL10 production and MHC class I upregulation. Importantly, we could demonstrate that IL-27 acts as a priming signal on keratinocytes able to amplify chemokine production and surface molecule expression when used before a second signal, such as TNF-alpha. The effects of IL-27 could not be mimicked by IL-6, IL-12, or IL-23.

CONCLUSION:

These results support the notion that IL-27 might act in an inflammatory, disease-maintaining manner in the epidermal compartment of patients with eczema.

PMID:
19523673
DOI:
10.1016/j.jaci.2009.04.026
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center